EPISODE · Jul 4, 2026 · 10 MIN
FDA批准新药olezarsen: 严重高甘油三酯血症的急性胰腺炎突破性治疗
from 消化肝病前沿资讯
FDA批准Ionis制药新药olezarsen扩大适应症，用于治疗严重高甘油三酯血症。该药曾获优先审评与突破性疗法认定，两项III期试验显示其可大幅降低甘油三酯水平，减少急性胰腺炎风险，每月皮下注射一次，为高危患者提供新选择。00:06新药获批与适应症扩展00:43加速审批与试验规模01:36惊人降脂数据公布02:23给药方式与副作用03:00不良反应应对方案03:52试验设计与权威发表04:25研究证据与对比优势05:11对比传统贝特类药物05:54适用人群与判断标准06:37联合饮食控制要点07:16价格预估与成本考量08:04停药反弹与用药依从08:40用药选择综合考量09:27获批意义与总结提醒
Embed this episode
Ready to play
FDA批准新药olezarsen: 严重高甘油三酯血症的急性胰腺炎突破性治疗
0:00
10:25
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 消化肝病前沿资讯?
This episode is 10 minutes long.
When was this 消化肝病前沿资讯 episode published?
This episode was published on July 4, 2026.
Can I download this 消化肝病前沿资讯 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!